NEW YORK, July 17, 2024 – Michelle Bair has joined the Human Immunome Project (HIP) as Vice President of Philanthropy, the organization announced today. “Michelle Bair is a powerhouse and we’re excited to have her join the team,” said CEO Hans Keirstead. “Michelle’s global experience, development expertise, and track record in major gifts and partnerships…
Read MoreScientists Develop First Universal Immune Health Metric
“A unified metric of human immune health,” published by a distinguished group of scientists in Nature Medicine in July 2024 – including HIP Co-Chief Science Officer John Tsang – developed a new way to measure how healthy your immune system is, called the Immune Health Metric (IHM). By studying blood samples from over 200 patients…
Read MoreNeema Mgana, PhD Joins the Human Immunome Project Board of Directors
NEW YORK, June 5, 2024 – The Human Immunome Project (HIP) is pleased to announce the appointment of Neema Mgana, PhD to the Board of Directors. “We are thrilled to have Dr. Mgana join the Human Immunome Project Board and contribute her expertise to our mission,” said Board Chair Jane Metcalfe. “Neema’s multilateral and global…
Read MoreHIP Unveils Scientific Plan to Decode and Model the Immune System
NEW YORK, April 29, 2024 – The Human Immunome Project (HIP), a global nonprofit scientific initiative, released its Scientific Plan today, on World Immunology Day, the organization announced. The plan provides a detailed roadmap of how the Human Immunome Project and its network of global study sites will generate the world’s largest and most diverse…
Read MoreAnnouncing 2023 Michelson Prize Laureates
Three early career scientists, Dr. Siyuan Ding, Dr. Claire Otero, and Dr. Dennis Schaefer-Babajew, to receive $150,000 Grants for immunology and vaccine research. NEW YORK, March 5, 2024 – The Human Immunome Project (HIP) and Michelson Medical Research Foundation (MMRF) have awarded Dr. Siyuan Ding (Washington University in St. Louis), Dr. Claire Otero (Weill Cornell…
Read MoreLaunching the Human Immunome Project
Key Takeaways from the Human Immunome Project Into Action Conference Just over a year ago, the Human Immunome Project (HIP) was initiated at a summit in La Jolla, California, drawing immunology leaders together to discuss the greatest challenge in the healthcare field. Since then we have introduced new leadership and new Board members, and launched…
Read More23andMe Founder Linda Avey Joins the Human Immunome Project Board of Directors
NEW YORK, November 30, 2023 – The Human Immunome Project (HIP) is pleased to announce the appointment of Linda Avey to the Board of Directors. “Linda’s scientific expertise and entrepreneurial spirit will be of immediate benefit to the Human Immunome Project as we pursue our mission to decode and model the human immune system,” said…
Read MoreScientific Consensus Builds on Effort to Map and Model Human Immune System
BARCELONA, November 21, 2023 – The Human Immunome Project Into Action Conference, hosted at CosmoCaixa Museum of Science by the CaixaResearch Institute and Human Immunome Project (HIP), concluded with agreement on a scientific strategy to map and model the human immune system, the groups announced today. The global effort, which will produce publicly available AI…
Read MoreActioning the Human Immunome Project
With a scientific plan now in place, the Human Immunome Project (HIP) is gearing up to begin implementation in early 2024. To set the stage, HIP, together with our partner CaixaResearch Institute, is hosting an “Into Action,” Conference to stress test the plan alongside global representatives from science, industry, government, and civil society, to agree…
Read MoreHIP 2.0: Unveiling Our Scientific Plan to Decode and Model the Immune System
At the Human Immunome Project, 2023 has been a year of great transition and progress. Learn how we plan to decode and model the immune system to transform the future of global health.
Read More